 Raw Story | Why the rejection of Novartis patent plea is a huge victory for India Firstpost After the granting of compulsory license by the government of India in March last to an Indian company (Natco Pharma) to locally produce Nexavar, a liver-kidney cancer drug, this has been the most eagerly awaited decision in the health sector. Nexavar ... India court ruling could deprive developing nations of patented drugs Patent problems Novartis order may force pharma MNCs to change |
